Armata Pharmaceuticals, Inc. (ARMP) stock
ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$3.17+0.51 (+19.17%)
Close on Nov 18, 2026Market cap $117.87MP/E –Yield –
Armata Pharmaceuticals pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Armata Pharmaceuticals's pe ratio was 1.5× on Jul 29, 2016, against 3.8× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2016 | Jul 29, 2016 | 1.5× | −43.1 |
| 2015 | Dec 31, 2015 | 44.6× | +41.3 |
| 2014 | Dec 31, 2014 | 3.2× | – |
See a number that looks wrong?